These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22408025)

  • 1. Transcription factor CHF1/Hey2 regulates EC coupling and heart failure in mice through regulation of FKBP12.6.
    Liu Y; Korte FS; Moussavi-Harami F; Yu M; Razumova M; Regnier M; Chin MT
    Am J Physiol Heart Circ Physiol; 2012 May; 302(9):H1860-70. PubMed ID: 22408025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bHLH transcription factor CHF1/Hey2 regulates susceptibility to apoptosis and heart failure after pressure overload.
    Liu Y; Yu M; Wu L; Chin MT
    Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2082-92. PubMed ID: 20382855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial deletion of transcription factor CHF1/Hey2 results in altered myocyte action potential and mild conduction system expansion but does not alter conduction system function or promote spontaneous arrhythmias.
    Hartman ME; Liu Y; Zhu WZ; Chien WM; Weldy CS; Fishman GI; Laflamme MA; Chin MT
    FASEB J; 2014 Jul; 28(7):3007-15. PubMed ID: 24687990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHF1/Hey2 promotes physiological hypertrophy in response to pressure overload through selective repression and activation of specific transcriptional pathways.
    Yu M; Liu Y; Xiang F; Li Y; Cullen D; Liao R; Beyer RP; Bammler TK; Chin MT
    OMICS; 2009 Dec; 13(6):501-11. PubMed ID: 20001863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditional FKBP12.6 overexpression in mouse cardiac myocytes prevents triggered ventricular tachycardia through specific alterations in excitation-contraction coupling.
    Gellen B; Fernández-Velasco M; Briec F; Vinet L; LeQuang K; Rouet-Benzineb P; Bénitah JP; Pezet M; Palais G; Pellegrin N; Zhang A; Perrier R; Escoubet B; Marniquet X; Richard S; Jaisser F; Gómez AM; Charpentier F; Mercadier JJ
    Circulation; 2008 Apr; 117(14):1778-86. PubMed ID: 18378612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHF1/Hey2 plays a pivotal role in left ventricular maturation through suppression of ectopic atrial gene expression.
    Koibuchi N; Chin MT
    Circ Res; 2007 Mar; 100(6):850-5. PubMed ID: 17332425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of FK506-binding protein FKBP12.6 in cardiomyocytes reduces ryanodine receptor-mediated Ca(2+) leak from the sarcoplasmic reticulum and increases contractility.
    Prestle J; Janssen PM; Janssen AP; Zeitz O; Lehnart SE; Bruce L; Smith GL; Hasenfuss G
    Circ Res; 2001 Feb; 88(2):188-94. PubMed ID: 11157671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of FKBP12.6 from ryanodine receptor type 2 is regulated by cyclic ADP-ribose but not beta-adrenergic stimulation in mouse cardiomyocytes.
    Zhang X; Tallini YN; Chen Z; Gan L; Wei B; Doran R; Miao L; Xin HB; Kotlikoff MI; Ji G
    Cardiovasc Res; 2009 Nov; 84(2):253-62. PubMed ID: 19578067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium/Calmodulin Protein Kinase II-Dependent Ryanodine Receptor Phosphorylation Mediates Cardiac Contractile Dysfunction Associated With Sepsis.
    Sepúlveda M; Gonano LA; Viotti M; Morell M; Blanco P; López Alarcón M; Peroba Ramos I; Bastos Carvalho A; Medei E; Vila Petroff M
    Crit Care Med; 2017 Apr; 45(4):e399-e408. PubMed ID: 27648519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol prevents the development of heart failure by restoring FKBP12.6-mediated stabilization of ryanodine receptor.
    Doi M; Yano M; Kobayashi S; Kohno M; Tokuhisa T; Okuda S; Suetsugu M; Hisamatsu Y; Ohkusa T; Kohno M; Matsuzaki M
    Circulation; 2002 Mar; 105(11):1374-9. PubMed ID: 11901051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy.
    Xin HB; Senbonmatsu T; Cheng DS; Wang YX; Copello JA; Ji GJ; Collier ML; Deng KY; Jeyakumar LH; Magnuson MA; Inagami T; Kotlikoff MI; Fleischer S
    Nature; 2002 Mar; 416(6878):334-8. PubMed ID: 11907581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4.
    Xiang F; Sakata Y; Cui L; Youngblood JM; Nakagami H; Liao JK; Liao R; Chin MT
    Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1997-2006. PubMed ID: 16603706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of carvedilol on ryanodine receptor in heart failure].
    Li R; Yi QJ; Qian YR; Liu XY
    Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):603-7. PubMed ID: 16191273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of cardiovascular anomalies in CHF1/Hey2 deficient mice reveals roles in endocardial cushion, myocardial and vascular maturation.
    Sakata Y; Koibuchi N; Xiang F; Youngblood JM; Kamei CN; Chin MT
    J Mol Cell Cardiol; 2006 Feb; 40(2):267-73. PubMed ID: 16242143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factor CHF1/Hey2 regulates coronary vascular maturation.
    Watanabe T; Koibuchi N; Chin MT
    Mech Dev; 2010; 127(9-12):418-27. PubMed ID: 20619341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure.
    Yano M; Kobayashi S; Kohno M; Doi M; Tokuhisa T; Okuda S; Suetsugu M; Hisaoka T; Obayashi M; Ohkusa T; Kohno M; Matsuzaki M
    Circulation; 2003 Jan; 107(3):477-84. PubMed ID: 12551874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered stoichiometry of FKBP12.6 versus ryanodine receptor as a cause of abnormal Ca(2+) leak through ryanodine receptor in heart failure.
    Yano M; Ono K; Ohkusa T; Suetsugu M; Kohno M; Hisaoka T; Kobayashi S; Hisamatsu Y; Yamamoto T; Kohno M; Noguchi N; Takasawa S; Okamoto H; Matsuzaki M
    Circulation; 2000 Oct; 102(17):2131-6. PubMed ID: 11044432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 4-induced ryanodine receptor 2 oxidation and sarcoplasmic reticulum Ca
    Yang J; Zhang R; Jiang X; Lv J; Li Y; Ye H; Liu W; Wang G; Zhang C; Zheng N; Dong M; Wang Y; Chen P; Santosh K; Jiang Y; Liu J
    J Biol Chem; 2018 Jan; 293(3):794-807. PubMed ID: 29150444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve.
    Li L; Li J; Drum BM; Chen Y; Yin H; Guo X; Luckey SW; Gilbert ML; McKnight GS; Scott JD; Santana LF; Liu Q
    Cardiovasc Res; 2017 Feb; 113(2):147-159. PubMed ID: 27856611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac G-protein-coupled receptor kinase 2 ablation induces a novel Ca2+ handling phenotype resistant to adverse alterations and remodeling after myocardial infarction.
    Raake PW; Zhang X; Vinge LE; Brinks H; Gao E; Jaleel N; Li Y; Tang M; Most P; Dorn GW; Houser SR; Katus HA; Chen X; Koch WJ
    Circulation; 2012 May; 125(17):2108-18. PubMed ID: 22496128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.